Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study

[News]

Low doses of the medication lasofoxifene can reduce the risk of vertebral and non-vertebral fractures, ER-positive breast cancer, coronary heart disease and stroke in postmenopausal women with osteoporosis. That's the finding of a new study in the latest issue of the New England Journal of Medicine.

More... (http://www.news-medical.net/news/20100225/Low-doses-of-lasofoxifene-reduce-all-common-problems-in-postmenopausal-women-Study.aspx)